|Published||Report Code||Available Format||Pages|
The global medical robotic systems market valued $7.6 billion in 2019, and it is projected to grow with a CAGR of 20.2% during the forecast period (2020–2030). The growing demand for robotic procedures, surging geriatric population leading to the rising demand for elderly care, increasing use of automated pharmacy systems, and rising healthcare and medical robotics expenditure are the key factors driving the growth of the medical robotic systems industry.
Moreover, due to the ongoing pandemic, the government of all COVID-19-affected countries is taking measures to restrict human touch in the healthcare industry, as well as are promoting social distancing, in order to restrain the spread of the disease. Considering the present situation, robotic systems are better suited for supporting the operations of hospitals, by sharing the work pressure of the healthcare staff. This, in turn, is expected to propel the growth of the medical robotic systems market in the coming years.
The surgical robotic systems category dominated the medical robotic systems market during the historical period (2014–2019), when segmented based on type. This category is further expected to progress with the fastest pace during the forecast period, to remain the largest. The growth of the category is primarily attributed to the increasing demand for minimally invasive robotic surgeries, which require lesser time and effort, as compared to manual surgeries.
During the historical period, the treatment category accounted for the largest share in the medical robotic systems market, when segmented on the basis of application. Moreover, the category is expected to retain its market domination in the forecast period. The market growth in this category is mainly buoyed by the advantages offered by robotic treatment procedures, such as high accuracy and less time requirement.
The cardiothoracic surgery category is projected to witness the fastest growth in the medical robotic systems market during the forecast period, among the various indications. This can be attributed to the widespread burden of cardiovascular diseases (CVDs) and advantages associated with robotic surgery, including minimal blood loss and pain to patients, which lead to a shorter recovery time than the traditional approach.
Hospitals and ASCs were the largest end users of medical robotic systems throughout the historical period. Furthermore, the category is expected to continue to create the highest demand in the medical robotic systems market during the forecast period. The dominance of the category is predominantly due to the increasing adoption of technologically advanced products, high efficiency of these systems, and large number of patients visiting hospitals to seek proper treatment.
The medical robotic systems market in North America is expected to remain the dominant one during the forecast period, advancing with the highest growth rate. The growth in the North American market can be attributed to the presence of giant players, well-structured healthcare system, rising demand for minimally invasive surgeries, and funding by the government for medical robots. Furthermore, market players are actively involved in strategic developments and focused on raising funds, to establish strong grounds in the industry.
For instance, in February 2019, Corindus Vascular Robotics Inc. raised $15 million in a stock offering. Similarly, Vicarious Surgical, a developer of virtual reality for minimally invasive procedures, raised $10 million in funding led by the The Bill & Melinda Gates Foundation. These factors are likely to boost the demand for medical robotic systems in the region.
The most significant trends in the medical robotic systems market are technological advancements and launch of new robots, for instance, microbot targeted therapy. According to the 2019 paper “Microrobots Show Promise for Treating Tumors” published by the California Institute of Technology in Daily Science, researchers are working on an entirely new form of treatment. The new microrobots utilize near-microscopic mechanical particles to locate the target site for a drug or other therapies and then deliver the drugs to a specific body part, while being monitored and controlled from outside the body.
According to a study published in the Journal of the American Medical Association (JAMA) in 2020, robot-assisted procedures accounted for 15.1% of all general surgeries in 2018, a rise of just 1.8% from 2012. The use of robotic surgeries jumped 8.8% in the first four years, after hospitals started adopting it. Among the specific procedures that were tracked in the study, inguinal hernia repair witnessed the highest growth in the use of robots, from 0.7% of the cases in 2012 to 28.8% in 2018. Such a growing adoption of robotic procedures in the medical field is expected to drive the demand in the medical robotic systems market.
The surging geriatric population plays an important role in the growth of the medical robotic systems market. According to a report published by United Nations (UN), in 2017, there were 962 million people aged 60 or above globally, and this number will increase to 2.1 billion in 2050 and 3.1 billion in 2100. The growing financial burden, coupled with the shortage in the number of caregivers, indicates the need for finding a more efficient way to care for the world’s elderly.
Researchers all around the world are proactively striving to solve this problem and working to create autonomous robots capable of performing similar, if not the exact same, tasks as caregivers. Thus, the booming aging population, coupled with the rising shortage of caregivers, is likely to have a positive impact on the medical robotic systems market.
The surging usage of automated pharmacy systems drives the growth of the medical robotic systems market. It reduces the time to locate the prescribed drugs in dispensaries and allows technicians and pharmacists to have more time with the patients. Its other advantages include the freeing up of space in the pharmacy, reduced dispensing errors, and lower patient waiting time. Due to such advantages, pharmacies are rapidly adopting these systems, hence boosting the growth of the medical robotic systems industry.
|Base Year (2019) Market Size||$7.6 Billion|
|Forecast Period (2020-2030) CAGR||20.2%|
|Report Coverage||Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Impact of COVID-19, Market Share Analysis, Companies’ Strategic Developments, Product Benchmarking, Company Profiling|
|Market Size by Segments||Type, Application, Indication, End User, Region|
|Market Size of Geographies||U.S., Canada, Germany, France, Italy, U.K., Spain, Japan, China, India, Brazil, Mexico, Saudi Arabia, South Africa|
|Secondary Sources and References (Partial List)||Clinical Robotic Surgery Association, American Association for Clinical Chemistry, Federal Institute for Drugs and Medical Devices, Food and Drug Administration, International Society for Medical Robotics, Medical Device Manufacturers Association, Society of Robotic Surgery|
The global medical robotic systems market is consolidated in nature, with the presence of players such as Intuitive Surgical Inc., Stereotaxis Inc., Accuracy Incorporated, Hocoma AG, Capsa Healthcare, and Medrobotics Corporation.
In recent years, players in the medical robotic systems industry have been involved in multiple strategic developments, in order to stay ahead of their competitors. For instance:
The medical robotic systems market report offers comprehensive market segmentation analysis along with market estimation for the period 2014–2030.
Based on Type
Based on Application
Based on Indication
Based on End User